Suministro de medicamentos exclusivos Mogamulizumab (POTELIGEO) y Burosumab (CRYSVITA)
Tender information
TED EUMadrid, Spain
- Type
- 29
- Procedure
- neg-wo-call
- Ref. number
- 413391-2024
- Estimated value
- 91,244 EUR
- CPV
- 33600000
Suministro de medicamentos exclusivos Mogamulizumab (POTELIGEO) y Burosumab (CRYSVITA)